GO:0043251 sodium-dependent organic anion transport: Bile Acid and Drug Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043251 sodium-dependent organic anion transport describes the directed, sodium-dependent movement of organic anions into, out of, or within a cell, typically via transporters or pores.
• The best-characterized mediators are the sodium-dependent organic anion transporter SOAT/SLC10A6 and the sodium taurocholate cotransporting polypeptide NTCP/SLC10A1.
• NTCP/SLC10A1 is the hepatic sinusoidal bile acid uptake transporter and also serves as the functional receptor for hepatitis B and D virus entry.
• SOAT/SLC10A6 transports sulfoconjugated steroids and bile acids and is implicated in steroid hormone homeostasis and cancer biology.
• Sodium-dependent organic anion transport is central to bile acid enterohepatic circulation, intestinal drug absorption, and hepatic drug uptake.
• CRISPR knockout, point mutation, knock-in, and overexpression cell models enable causal dissection of transporter function and disease relevance.
Description
Sodium-dependent organic anion transport (GO:0043251) is a biological process defined as the directed, sodium-dependent movement of organic anions into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Organic anions in this context include bile acids, sulfoconjugated steroids, and certain anionic drugs, and their sodium-dependent transport is essential for liver, intestine, and kidney physiology. The process is mediated by solute carrier (SLC) transporters, most notably SOAT/SLC10A6 and NTCP/SLC10A1, which couple substrate movement to the sodium gradient. Researchers study this process because it governs bile acid homeostasis, drug pharmacokinetics, and susceptibility to viral infection. Dysregulation of sodium-dependent organic anion transport has been linked to cholestatic liver disease, metabolic disorders, and cancer, making it a target for therapeutic and diagnostic development. In this article, we summarize the definition, mechanism, key genes, disease links, and experimental methods for studying GO:0043251, with emphasis on CRISPR-based models.
sodium-dependent organic anion transport At A Glance
| GO ID | GO:0043251 |
|---|---|
| GO term | sodium-dependent organic anion transport |
| Ontology | biological_process |
| Synonym | none |
| Definition | The directed, sodium-dependent, movement of organic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| Major function | Sodium-coupled translocation of organic anions such as bile acids, sulfoconjugated steroids, and anionic drugs across cellular membranes. |
| Representative transporters | SOAT/SLC10A6, NTCP/SLC10A1, and related SLC family members. |
| Physiological context | Hepatic bile acid uptake, enterohepatic circulation, intestinal absorption, and steroid hormone homeostasis. |
| Disease relevance | Cholestasis, metabolic disorders, hepatitis B/D virus entry, and cancer. |
What Is GO:0043251?
In our own words, GO:0043251 sodium-dependent organic anion transport is the process by which organic anions are moved across or within cells in a directed manner that requires sodium ions. The movement is typically mediated by transporter proteins or pores that couple the electrochemical sodium gradient to the translocation of anionic substrates. This term captures both uptake and efflux steps and can occur at the plasma membrane or within intracellular compartments, depending on the transporter involved.
Why Is sodium-dependent organic anion transport Important in Cell Biology?
Sodium-dependent organic anion transport is important because it controls the cellular entry and distribution of bile acids, steroid sulfates, and anionic drugs, thereby influencing liver function, intestinal physiology, and drug disposition. Because NTCP/SLC10A1 also mediates hepatitis B and D virus entry, this process is directly relevant to viral pathogenesis and antiviral strategies. Moreover, altered expression or function of transporters such as SOAT/SLC10A6 has been associated with metabolic and malignant phenotypes, underscoring its translational value.
• Maintains bile acid homeostasis through hepatic uptake and enterohepatic circulation.
• Enables intestinal absorption and transport of bile acids and anionic drugs.
• Mediates hepatic uptake of anionic drugs such as pitavastatin, affecting pharmacokinetics.
• Serves as the entry receptor for hepatitis B and D viruses via NTCP/SLC10A1.
• Regulates sulfoconjugated steroid transport and steroid hormone availability via SOAT/SLC10A6.
• Contributes to metabolic disorders such as post-bariatric hypoglycaemia through altered bile acid transport.
• Is implicated in cancer biology through altered expression of SOAT/SLC10A6.
• Provides a target for drug delivery strategies exploiting bile acid transporters.
• Offers a mechanistic basis for understanding cholestatic liver disease and transporter-mediated toxicity.
• Supports development of CRISPR models to causally test transporter gene function.
What Happens During sodium-dependent organic anion transport?
Substrate recognition and sodium coupling
In simple terms: The transporter first grabs the organic anion and a sodium ion together.
Sodium-dependent organic anion transporters recognize specific anionic substrates, such as bile acids or sulfoconjugated steroids, and couple their translocation to the sodium gradient. For example, NTCP/SLC10A1 mediates sodium-dependent uptake of taurocholate and other bile acids at the hepatic sinusoidal membrane. SOAT/SLC10A6 similarly transports sulfoconjugated steroids and bile acids in a sodium-dependent manner. This coupling ensures directed transport against concentration gradients.
Translocation across the membrane
In simple terms: The transporter then flips the substrate across the cell membrane.
After binding, the transporter undergoes conformational changes that move the organic anion across the lipid bilayer, either into or out of the cell. This step is driven by the sodium electrochemical gradient and can occur at the plasma membrane or in intracellular membranes. The direction of transport depends on the transporter's localization and the cellular context.
Cellular and systemic consequences
In simple terms: Once inside, the anion affects cell function and whole-body physiology.
Transported organic anions participate in metabolic and signaling pathways; for instance, bile acids regulate glucose and lipid metabolism and can influence post-bariatric hypoglycaemia. In the liver, sodium-dependent uptake of bile acids is essential for bile formation and cholesterol elimination. In the intestine, bile acid transporters contribute to drug absorption and enterohepatic recycling.
Pathogen entry and disease links
In simple terms: Some viruses hijack these transporters to enter cells.
NTCP/SLC10A1 acts as the functional receptor for hepatitis B and D virus entry, linking sodium-dependent organic anion transport to viral infection. CDC42 supports HBV entry by promoting NTCP translocation to the plasma membrane and macropinocytosis. This highlights how the transport process can be subverted in disease.
Pharmacological and therapeutic implications
In simple terms: Drugs can be designed to use or block these transporters.
Hepatic transporter-mediated uptake of anionic drugs such as pitavastatin can be predicted and quantified using in vitro models. Bile acid transporter-mediated oral drug delivery is an active area of research, exploiting these pathways for targeted delivery. Inhibitors of NTCP are being explored to block HBV entry.
Key Genes Involved in GO:0043251 sodium-dependent organic anion transport
The following genes encode transporters and related proteins that mediate or regulate sodium-dependent organic anion transport.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC10A6 | Sodium-dependent organic anion transporter (SOAT) for sulfoconjugated steroids and bile acids | Steroid hormone homeostasis, cancer biology |
| SLC10A1 | Sodium taurocholate cotransporting polypeptide (NTCP); hepatic bile acid uptake | Bile acid physiology, HBV/HDV entry |
| SLC10A2 | Apical sodium-dependent bile acid transporter (ASBT) in intestine | Intestinal bile acid absorption, drug delivery |
| SLC22A1 | Organic cation transporter 1 (OCT1); can transport some anions | Drug disposition, hepatic uptake |
| SLC22A7 | Organic anion transporter 2 (OAT2) | Hepatic drug transport |
| SLCO1B1 | Organic anion transporting polypeptide 1B1 (OATP1B1) | Statin uptake, drug-drug interactions |
| SLCO1B3 | Organic anion transporting polypeptide 1B3 (OATP1B3) | Hepatic drug uptake |
| ABCB11 | Bile salt export pump (BSEP) | Bile acid efflux, cholestasis |
| ABCC2 | Multidrug resistance-associated protein 2 (MRP2) | Bile acid and drug efflux |
| CDC42 | Rho GTPase involved in NTCP translocation and macropinocytosis | HBV entry mechanism |
| NR1H4 | Farnesoid X receptor (FXR); regulates bile acid transporters | Bile acid homeostasis |
| SLC51A | Organic solute transporter alpha (OSTalpha) | Bile acid transport |
| SLC51B | Organic solute transporter beta (OSTbeta) | Bile acid transport |
| SLC10A3 | Putative sodium-dependent transporter | Less characterized; potential research target |
| SLC10A4 | Putative sodium-dependent transporter | Less characterized; potential research target |
| SLC10A5 | Putative sodium-dependent transporter | Less characterized; potential research target |
| SLC10A7 | Putative sodium-dependent transporter | Less characterized; potential research target |
How Is sodium-dependent organic anion transport Regulated?
Sodium-dependent organic anion transport is regulated at multiple levels. The nuclear receptor FXR (NR1H4) controls expression of bile acid transporters such as NTCP and BSEP, thereby adjusting transport capacity to bile acid load. Post-translational regulation includes CDC42-dependent translocation of NTCP to the plasma membrane, which is required for HBV entry. Hormonal and metabolic signals can also modulate transporter activity, as seen in post-bariatric hypoglycaemia where bile acid transport alterations contribute to pathophysiology. Additionally, substrate availability and sodium gradient maintenance influence transport rates.
sodium-dependent organic anion transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC10A1 | Hepatitis B/D virus entry, cholestasis | NTCP knockout hepatoma cells, HBV infection assay |
| SLC10A6 | Steroid hormone-dependent cancer | SOAT knockout or overexpression cell lines |
| SLC10A2 | Bile acid malabsorption, drug delivery | Intestinal epithelial KO models |
| ABCB11 | Progressive familial intrahepatic cholestasis | BSEP mutant knock-in hepatocytes |
| CDC42 | HBV entry regulation | CDC42 knockout or point-mutation cells |
Cholestatic liver disease and bile acid transport disorders
Impaired sodium-dependent bile acid uptake or efflux can lead to cholestasis and liver injury. NTCP/SLC10A1 and BSEP/ABCB11 are key players in bile acid homeostasis, and their dysfunction is associated with cholestatic phenotypes. Mutations in bile acid transporters can cause progressive familial intrahepatic cholestasis and related disorders.
Hepatitis B and D virus infection
NTCP/SLC10A1 is the functional receptor for hepatitis B and D virus entry, making sodium-dependent organic anion transport a critical host factor for infection. CDC42 supports HBV entry by promoting NTCP translocation to the plasma membrane and macropinocytosis, highlighting a regulatory node that could be targeted therapeutically.
Metabolic disorders and post-bariatric hypoglycaemia
Alterations in intestinal bile acid transport have been identified as a therapeutic target in patients with post-bariatric hypoglycaemia, linking sodium-dependent organic anion transport to glucose metabolism. This suggests that modulating bile acid transport could improve metabolic outcomes.
Cancer and steroid hormone-dependent pathologies
SOAT/SLC10A6 transports sulfoconjugated steroids and is implicated in steroid hormone homeostasis and cancer biology. Altered expression of SOAT may affect hormone availability in hormone-dependent cancers, making it a potential biomarker or therapeutic target.
From sodium-dependent organic anion transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC10A6 mediate sodium-dependent steroid sulfate transport? | SLC10A6 knockout and overexpression cell lines |
| Is NTCP required for HBV entry? | SLC10A1 knockout hepatoma cells |
| How does CDC42 regulate NTCP translocation? | CDC42 point-mutation or knockout cells |
| What is the impact of bile acid transporter mutations on cholestasis? | Knock-in of patient mutations in ABCB11 or SLC10A1 |
| Can bile acid transporters be exploited for drug delivery? | Tagged knock-in of SLC10A2 for trafficking studies |
| Does altered bile acid transport contribute to post-bariatric hypoglycaemia? | Intestinal transporter knockout mouse models |
How to Study the sodium-dependent organic anion transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled substrate uptake | Sodium-dependent transport activity | Characterizing SOAT or NTCP function |
| CRISPR knockout screen | Genes required for transport or viral entry | Identifying host factors for HBV entry |
| Proteomics | Protein expression and interactions | Discovering transporter-associated proteins |
| Fluorescence microscopy | Subcellular localization and trafficking | Studying NTCP translocation |
| qPCR/Western blot | Transporter mRNA and protein levels | Validating knockout or overexpression |
| Mechanistic modeling | Prediction of transporter-mediated uptake | Quantifying hepatic drug uptake |
| Intestinal perfusion models | Bile acid absorption in vivo | Studying post-bariatric hypoglycaemia |
| Drug delivery assays | Transporter-mediated oral drug absorption | Developing bile acid-conjugated drugs |
Transport assays with radiolabeled substrates
Sodium-dependent organic anion transport is commonly measured using radiolabeled substrates such as taurocholate or sulfoconjugated steroids in cell lines expressing the transporter of interest. These assays quantify uptake in the presence and absence of sodium to confirm sodium dependence.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for sodium-dependent organic anion transport or for pathogen entry via NTCP. Such screens have been used to discover host factors for HBV entry, including CDC42.
Proteomics and interactomics
Proteomic approaches can identify proteins associated with transporters or involved in their trafficking, such as CDC42 for NTCP. Mass spectrometry-based methods can also quantify transporter expression in tissues.
Imaging and trafficking studies
Fluorescence microscopy of tagged transporters can reveal subcellular localization and translocation dynamics, as shown for NTCP and CDC42. These methods help link transport activity to cellular trafficking.
How CRISPR Can Be Used to Study GO:0043251 sodium-dependent organic anion transport
Knockout
CRISPR knockout of SLC10A6 or SLC10A1 can abolish sodium-dependent organic anion transport, providing causal evidence for transporter function. Knockout cell lines are used to test substrate specificity and viral entry.
Point Mutation
Point mutations can be introduced to mimic patient variants or to dissect residues required for sodium coupling or substrate binding. For example, mutations in NTCP can affect HBV entry without abolishing bile acid transport.
Knock-in
Knock-in of tagged transporters (e.g., GFP or HA) allows visualization of trafficking and localization. Knock-in of disease-associated mutations can model cholestatic disorders.
Overexpression
Overexpression of SLC10A6 or SLC10A1 in cell lines enhances transport activity and can be used to study drug uptake or viral entry. Overexpression models are also useful for screening inhibitors.
How EDITGENE Supports sodium-dependent organic anion transport Research
Researchers studying sodium-dependent organic anion transport-related genes often need to determine whether a candidate gene is causally involved in substrate translocation, disease susceptibility, or drug response. EDITGENE provides CRISPR-based cell model services to enable such causal experiments with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for sodium-dependent organic anion transport research.
Frequently Asked Questions About sodium-dependent organic anion transport
What is GO:0043251 sodium-dependent organic anion transport?
GO:0043251 is a Gene Ontology biological process describing the directed, sodium-dependent movement of organic anions into, out of, or within a cell, typically via transporters or pores.
What genes are involved in sodium-dependent organic anion transport?
Key genes include SLC10A6 (SOAT), SLC10A1 (NTCP), SLC10A2 (ASBT), and related SLC transporters.
What is the role of SLC10A6 in organic anion transport?
SLC10A6 encodes SOAT, a sodium-dependent transporter for sulfoconjugated steroids and bile acids, implicated in steroid hormone homeostasis and cancer.
How does NTCP/SLC10A1 function in bile acid transport?
NTCP/SLC10A1 mediates sodium-dependent uptake of bile acids at the hepatic sinusoidal membrane and also serves as the receptor for hepatitis B and D virus entry.
Is sodium-dependent organic anion transport involved in disease?
Yes, it is linked to cholestasis, metabolic disorders, hepatitis B/D infection, and cancer.
How can I study sodium-dependent organic anion transport in the lab?
Common methods include radiolabeled substrate uptake assays, CRISPR knockout screens, proteomics, and imaging of tagged transporters.
What CRISPR models are available for studying SLC10A6?
Knockout, point mutation, knock-in, and overexpression cell models can be generated to study SLC10A6 function.
Does sodium-dependent organic anion transport affect drug absorption?
Yes, bile acid transporters can mediate oral drug delivery and hepatic uptake of anionic drugs such as pitavastatin.
What is the relationship between NTCP and hepatitis B virus?
NTCP/SLC10A1 is the functional receptor for HBV and HDV entry, and CDC42 supports this process by promoting NTCP translocation.
How does EDITGENE support research on GO:0043251?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services for transporter research.
Conclusion
Sodium-dependent organic anion transport (GO:0043251) is a fundamental biological process that governs the cellular movement of bile acids, steroid sulfates, and anionic drugs. Its mediators, including SOAT/SLC10A6 and NTCP/SLC10A1, are critical for liver and intestinal physiology, drug disposition, and host-pathogen interactions. Dysregulation of this process contributes to cholestasis, metabolic disorders, viral infection, and cancer, making it a compelling target for therapeutic development. CRISPR-based cell models offer powerful tools to dissect the causal roles of individual transporters and to accelerate translational research in this field.
References
- 1. Wannowius M et al.. 2023. Role of the Sodium-Dependent Organic Anion Transporter (SOAT/SLC10A6) in Physiology and Pathophysiology.. Int J Mol Sci 24(12) PMID: 37373074
- 2. Chaudhari SN et al.. 2025. Alterations in intestinal bile acid transport provide a therapeutic target in patients with post-bariatric hypoglycaemia.. Nat Metab 7(4):792-807 PMID: 40186075
- 3. Yan H et al.. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.. Elife 1:e00049 PMID: 23150796
- 4. Dawson PA et al.. 2009. Bile acid transporters.. J Lipid Res 50(12):2340-57 PMID: 19498215
- 5. Meier PJ et al.. 2002. Bile salt transporters.. Annu Rev Physiol 64:635-61 PMID: 11826283
- 6. Cui S et al.. 2025. CDC42 supports HBV entry by NTCP translocation to the plasma membrane and macropinocytosis.. EMBO Rep 26(21):5239-5269 PMID: 40954218
- 7. Mitra P et al.. 2018. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.. Drug Metab Dispos 46(7):953-963 PMID: 29666154
- 8. Deng F et al.. 2020. Bile acid transporter-mediated oral drug delivery.. J Control Release 327:100-116 PMID: 32711025
